• EPO-Modified MSCs Enhance Mitochondrial Transfer and Allevia

  2026-06-15

  Zhang et al. (2025) demonstrate that erythropoietin-modified bone marrow mesenchymal stem cells (EPO-BM-MSCs) alleviate asthma inflammation by upregulating HO-1, promoting mitochondrial transfer to injured epithelial cells via tunneling nanotubes. These mechanistic insights suggest novel strategies to target mitochondrial dysfunction in airway diseases.

• Triterpene Self-Assembled Prodrugs for Targeted OSCC Therapy

  2026-06-15

  This study presents a carrier-free, self-assembled prodrug system using triterpenes glycyrrhetinic acid and ginsenoside Rh2 for targeted chemotherapy of oral squamous cell carcinoma (OSCC). The innovative design leverages ROS-responsive linkers for enhanced, self-boosted drug release, demonstrating effective tumor targeting and minimized systemic toxicity.

• Carrier-Free Triterpene Prodrugs for Targeted OSCC Treatment

  2026-06-14

  This study presents a self-assembled, carrier-free triterpene-based prodrug system that achieves targeted chemotherapy for oral squamous cell carcinoma (OSCC). By leveraging ROS-responsive linkers and dual triterpene synergy, the platform enhances drug selectivity and release, offering a promising approach for effective and low-toxicity OSCC therapy.

• HotStart™ 2X Green qPCR Master Mix: Precision for CNS Infect

  2026-06-13

  Explore how HotStart 2X Green qPCR Master Mix empowers high-sensitivity SYBR Green qPCR for challenging CNS infection research. Discover unique assay strategies inspired by recent advances in host-pathogen dynamics and neuroinflammation.

• Pam3CSK4: TLR1/2 Agonist Workflows for Immune Modulation

  2026-06-12

  Pam3CSK4, as a TLR1/2 agonist, unlocks precise control over innate immune activation and inflammatory modeling for translational research. This guide delivers actionable protocols, troubleshooting expertise, and cross-domain insights, spotlighting how APExBIO’s reagent streamlines complex immune assays and bridges neuro-immune experimental designs.

• Deracoxib and Piroxicam Effects on Canine Osteosarcoma Cells

  2026-06-12

  This study systematically evaluates the cytotoxicity of deracoxib and piroxicam on canine osteosarcoma cell lines in vitro, revealing that deracoxib is more potent than piroxicam at inhibiting osteosarcoma cell viability, but neither induces apoptosis at tested concentrations. The findings refine our understanding of NSAID mechanisms in sarcoma models and highlight the importance of targeted approaches for improved therapeutic efficacy.

• Gap26: Advancing Connexin 43 Modulation in Translational Res

  2026-06-11

  This thought-leadership article unpacks the mechanistic, experimental, and strategic value of Gap26, a connexin 43 mimetic peptide, for translational scientists. Building on the latest evidence, it provides actionable guidance for deploying Gap26 in models of calcium signaling, ATP release, and intercellular communication, while positioning its use at the frontier of neuroprotection and vascular research. The piece synthesizes competitive insights and protocol nuances, highlights the translational relevance of gap junction modulation, and outlines future directions for clinical innovation.

• Low-Cost OP-DLP Enables High-Throughput Hydrogel Printing

  2026-06-11

  The reference study introduces an open-platform digital light printer (OP-DLP) designed for precise hydrogel printing and spatial light-activation in 96-well formats. This platform offers an affordable, adaptable alternative for producing thin, reproducible hydrogels and spatially modifying biomaterials, with broad implications for high-throughput cell adhesion and signaling research.

• BOP Reagent: Advanced Strategies for Peptide Synthesis Preci

  2026-06-10

  Unlock the scientific mechanisms and workflow enhancements enabled by BOP reagent (benzotriazol-1-yloxy-tris(dimethylamino)phosphanium hexafluorophosphate) in peptide synthesis. This deep-dive reveals nuanced applications, comparative insights, and reference-backed innovations for next-generation peptide workflows.

• Ganetespib (STA-9090) in Cancer Research: Protocols & Innova

  2026-06-10

  Ganetespib (STA-9090) offers high-potency, non-geldanamycin Hsp90 inhibition for advanced cancer research, enabling robust tumor growth studies and mechanistic insights. This guide distills optimized workflows, troubleshooting strategies, and novel cross-domain lessons from recent mechanistic discoveries.

• Cycloheximide in Translational Research: Mechanisms and Stra

  2026-06-09

  Cycloheximide’s role as a gold-standard protein biosynthesis inhibitor is pivotal for dissecting eukaryotic translation, apoptosis, and mitochondrial homeostasis. This article provides mechanistic insight, strategic protocol guidance, and translational perspectives, integrating evidence from recent studies on ARC pathogenesis and mitochondrial dysfunction. We position APExBIO’s Cycloheximide (SKU: A8244) as a rigorously validated tool for advanced translational research, bridging mechanistic discovery and disease modeling.

• KR-12 and LL-37 Fragments Inhibit MDR Acinetobacter Biofilms

  2026-06-09

  This study demonstrates that the human antimicrobial peptide LL-37 and its minimal fragments, including KR-12, exhibit both antimicrobial and anti-biofilm activities against multidrug-resistant Acinetobacter baumannii. The findings highlight the translational value of truncated human peptides as potential alternatives for challenging nosocomial infections.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Decoding Proteasome Inhibitio

  2026-06-08

  Explore the unique mechanistic insights of MG-262 (Z-Leu-Leu-Leu-B(OH)2) as a proteasome inhibitor for apoptosis research and cell cycle arrest studies. This article delivers an advanced analysis, bridging cutting-edge findings with practical assay optimization.

• Guanabenz Acetate: Applied Workflows for α2-Adrenergic Recep

  2026-06-08

  Guanabenz Acetate empowers precise modulation of α2-adrenergic receptor subtypes, enabling advanced dissection of GPCR signaling and immune response pathways. This guide translates recent stress granule and innate immunity breakthroughs into actionable protocols, troubleshooting strategies, and comparative insights for neuroscience and virology research.

• HotStart Universal 2X Green qPCR Master Mix: Precision Workf

  2026-06-07

  Unlock superior specificity and robust gene expression quantification with HotStart Universal 2X Green qPCR Master Mix. This APExBIO solution streamlines real-time PCR analysis, ensuring accurate DNA amplification monitoring and melt curve-based assay validation for advanced translational research.

16066 records 1/1072 page Next 12345 下5页 Last page